| Genotypes |
Metabolic syndrome |
P for χ2 test |
Age-adjusted OR (95%CI)* |
P for trend |
| Present (%) |
No present (%) |
| Men |
|
|
|
|
|
| TCF7L2-rs290487 |
|
|
0.903 |
|
0.631 |
| TT |
48 (44.0) |
74 (41.6) |
|
1.00 |
|
| CT |
50 (45.9) |
84 (47.2) |
|
1.09 (0.66,1.81) |
|
| CC |
11 (10.1) |
20 (11.2) |
|
1.20 (0.53, 2.73) |
|
| CDKAL1-rs9465871 |
|
|
0.850 |
|
0.651 |
| CC |
33 (30.3) |
53 (29.4) |
|
1.00 |
|
| CT |
56 (51.4) |
89 (49.4) |
|
0.99 (0.57,1.72) |
|
| TT |
20 (18.4) |
38 (21.2) |
|
1.20(0.60, 2.40) |
|
| 13q31.1-rs1359790 |
|
|
0.496 |
|
0.306 |
| GG |
58 (54.7) |
83 (47.4) |
|
1.00 |
|
| AG |
39 (36.8) |
75 (42.9) |
|
1.35 (0.81, 2.25) |
|
| AA |
9 (8.5) |
17 (9.7) |
|
1.29(0.54, 3.11) |
|
| Women |
|
|
|
|
|
| TCF7L2-rs2904987 |
|
|
0.984 |
|
0.976 |
| TT |
96 (40.3) |
149 (40.3) |
|
1.00 |
|
| CT |
111 (46.6) |
171 (46.2) |
|
0.98 (0.68, 1.40) |
|
| CC |
31 (13.0) |
50 (13.5) |
|
1.00 (0.59, 1.71) |
|
| CDKAL1-rs9465871 |
|
|
0.343 |
|
0.827 |
| CC |
66 (26.9) |
113 (30.5) |
|
1.00 |
|
| CT |
127 (51.8) |
170 (45.8) |
|
0.77 (0.52, 1.14) |
|
| TT |
52 (21.2) |
88 (23.7) |
|
0.98(0.61, 1.56) |
|
| 13q31.1-rs1359790 |
|
|
0.247 |
|
0.107 |
| GG |
120 (49.4) |
201 (55.5) |
|
1.00 |
|
| AG |
103 (42.4) |
140 (38.7) |
|
0.85 (0.60, 1.20) |
|
| AA |
20 (8.2) |
21 (5.8) |
|
0.58(0.30, 1.14) |
|
*OR, odds ratio; 95%CI, 95% confidence interval.
|
